<SEC-DOCUMENT>0000950170-21-001776.txt : 20210913
<SEC-HEADER>0000950170-21-001776.hdr.sgml : 20210913
<ACCEPTANCE-DATETIME>20210913081445
ACCESSION NUMBER:		0000950170-21-001776
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210913
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210913
DATE AS OF CHANGE:		20210913

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adicet Bio, Inc.
		CENTRAL INDEX KEY:			0001720580
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813305277
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38359
		FILM NUMBER:		211248682

	BUSINESS ADDRESS:	
		STREET 1:		200 CLARENDON  STREET
		STREET 2:		FLOOR 6
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-482-2333

	MAIL ADDRESS:	
		STREET 1:		200 CLARENDON  STREET
		STREET 2:		FLOOR 6
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	resTORbio, Inc.
		DATE OF NAME CHANGE:	20171024
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>acet-20210913.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-09-13T08:11:42.8956+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:acet="http://www.adicetbio.com/20210913" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_93798d6e-35e1-4928-a295-4eb22b36ffc7" name="dei:EntityCentralIndexKey" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d">0001720580</ix:nonNumeric><ix:nonNumeric id="F_ce5e52bf-24ea-4f12-acd4-11ba23d2eb9b" name="dei:AmendmentFlag" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="acet-20210913.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001720580</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-13</xbrli:startDate><xbrli:endDate>2021-09-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">UNITED STATES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;">WASHINGTON, D.C. 20549</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">FORM </span><span style="font-size:18.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ad3148f1-9990-4bb3-bb17-74857b48498f" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;">CURRENT REPORT</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Date of Report (Date of earliest event reported): </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8a241946-ae7b-441a-9c95-d0046f22409c" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 13, 2021</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aed735fb-6834-46bc-9dd7-e6d494bc66db" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:Times New Roman;">Adicet Bio, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Exact name of registrant as specified in its charter)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.333%;"></td>
    <td style="width:33.343%;"></td>
    <td style="width:33.324%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fb4ba229-ed0f-4eeb-8393-497fd8f442da" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2159da06-2376-4876-ae89-d239e2b7c0ce" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">001-38359</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cc045c55-8701-4a57-ae15-b12d2556c0b0" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">81-3305277</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(State or Other Jurisdiction</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">of Incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Commission File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(IRS Employer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Identification No.)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:1.581%;"></td>
    <td style="width:31.416%;"></td>
    <td style="width:33.502%;"></td>
    <td style="width:33.502%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br /> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7413b0be-df56-431f-b578-2293db1f069e" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">200 Clarendon Street</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d5ea3e72-61dd-4d00-8776-f5e482904fa2" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Floor 6</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_37fe0a2d-cf70-4d06-bda1-dcee1b6e1213" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Boston</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4aa4db30-45ec-45bc-8106-544049c751cb" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityAddressStateOrProvince"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">MA</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_59abc986-b8af-4bc3-bbb4-6f553820af3c" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">02116</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Registrant&#x2019;s telephone number, including area code: (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d4262438-215e-4588-8d84-b75e371c7b08" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">650</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">) </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c3036e14-7b28-4c06-9da1-bb2d199cfd62" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">503-9095</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Not Applicable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Former Name or Former Address, if Changed Since Last Report)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bcdb014e-22d0-42a8-9e7c-6766001924ed" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7be2fef5-c739-4d64-b637-91b803c388f9" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dc3db100-396e-4a37-9aa0-97c0e7b61499" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_37149958-c2a4-4727-9061-1a32efc47505" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:42.641%;"></td>
    <td style="width:19.055%;"></td>
    <td style="width:38.304%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.500pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title of each class</span></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;padding-left:0.075in;vertical-align:middle;border-bottom:0.500pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Trading Symbol(s)</span></p></td>
    <td style="border-top:0.500pt solid;background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;padding-left:0.075in;vertical-align:middle;border-bottom:0.500pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;border-left:0.500pt solid;padding-left:0.075in;vertical-align:middle;border-bottom:0.500pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8dbdacf8-445b-4c33-ba30-e0add30e9f64" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;padding-left:0.075in;vertical-align:middle;border-bottom:0.500pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f0774688-6ada-42ae-9810-952390adff17" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ACET</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.500pt solid;word-break:break-word;padding-left:0.075in;vertical-align:middle;border-bottom:0.500pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5d1914da-8a4b-4f82-81f5-425393dbbd8d" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x2009;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x2009;240.12b-2 of this chapter).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Emerging growth company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8614d6a0-de07-4731-8dde-1a27ba5f0bb6" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_411aa4c1-f9ff-4dfe-b609-f611f45bfe52" contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="border-top:0.500pt solid rgba(0,0,0,1);text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="border-top:1.000pt solid;padding-top:1.0pt;text-indent:0.0%;font-size:10.0pt;margin-top:1.0pt;line-height:1.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 7.01   Regulation FD Disclosure</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On September 13, 2021, Adicet Bio, Inc. (the &#x201c;Adicet&#x201d;) issued a press release titled &#x201c;Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics,&#x201d; a copy of which is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The information in this Item 7.01, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 8.01   Other Events</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On September 13, 2021, Adicet and Twist Bioscience Corporation (&#x201c;Twist&#x201d;) issued a joint press release announcing a collaboration to accelerate the discovery of gamma delta T cell therapies against five undisclosed targets. The companies will work together to engineer immune cells with fully human chimeric antigen receptors (&#x201c;CARs&#x201d;) and T-cell receptors (TCRs) directed to disease-specific cell surface antigens. This precise and targeted engagement is designed to provide a superior potential to facilitate recognition and killing of tumor cells.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the terms of the collaboration, Twist will leverage its proprietary single chain fragment variable (scFv) and VHH (nanobody) technologies from its Library of Libraries to discover unique target-specific binders. These targeting technologies will enable the Adicet&#x2019;s engineering and discovery of unique CARs used in the generation of novel gamma delta CAR T cell products. Twist will receive an upfront technology license fee for each program as well as clinical and regulatory milestones and royalties for any product resulting from the selected targets.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">disclosure under this Item 8.01 contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 relating to business and operations of Adicet including, but not limited to, express or implied statements regarding the potential benefits resulting from the collaboration with Twist to Adicet&#x2019;s business or strategy, including Adicet&#x2019;s ability to rapidly identify and optimize unique antibodies and related target-engagement technologies to facilitate Adicet&#x2019;s CAR pipeline, the payment of upfront license fees and potential milestone and royalty payments under the collaboration, the expected potential therapeutic effects of Adicet&#x2019;s product candidates, and expectations regarding the timing and success of preclinical and clinical development of Adicet&#x2019;s product candidates, including in connection with the collaboration. Any forward-looking statements in the disclosure under this Item 8.01 are based on management&#x2019;s current expectations and beliefs of future events, and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements, including without limitation, the effect of COVID-19 on Adicet&#x2019;s business and financial results, including with respect to disruptions to its clinical trials and business operations; future clinical studies may fail to demonstrate adequate safety and efficacy of Adicet&#x2019;s product candidates, which would prevent, delay, or limit the scope of regulatory approval and commercialization; regulatory approval processes of the FDA and comparable foreign regulatory authorities are lengthy, time-consuming, and inherently unpredictable; as well as those risks and uncertainties set forth in Adicet&#x2019;s most recent annual report on Form 10-K and subsequent filings with the Securities and Exchange Commission (SEC). For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause Adicet&#x2019;s actual results to differ from those contained in the forward-looking statements, see the section entitled &#x201c;Risk Factors&#x201d; in Adicet&#x2019;s most recent annual report on Form 10-K and periodic reports on Form 10-Q and Form 8-K filed with the SEC, as well as discussions of potential risks, uncertainties, and other important factors in Adicet&#x2019;s other filings with the SEC. All disclosure under this Item 8.01 is as of the date of this Form 8-K, and Adicet undertakes no duty to update this information unless required by law.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9.01    Financial Statements and Exhibits</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d) Exhibits</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.0%;"></td>
    <td style="width:2.0%;"></td>
    <td style="width:89.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Description</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">99.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="acet-20210913ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Press release issued by Adicet Bio, Inc. on September 13, 2021, furnished herewith.</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cover Page Interactive Data File</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="fis_unidentified_table_2"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.954%;"></td>
    <td style="width:4.583%;"></td>
    <td style="width:6.278%;"></td>
    <td style="width:44.185%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ADICET BIO, INC.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: September 13, 2021</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Chen Schor</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Name:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Chen Schor</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Title:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">President and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>acet-20210913ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><img src="img44277468_0.jpg" alt="img44277468_0.jpg" style="width:221px;height:86px;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">		</font><img src="img44277468_1.jpg" alt="img44277468_1.jpg" style="width:212px;height:58px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">MENLO PARK, Calif., and BOSTON, MA, and SOUTH SAN FRANCISCO, Calif. &#x2013; September 13, 2021</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;"> &#x2013; Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, and Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration to accelerate the discovery of gamma delta T cell therapies against five undisclosed targets. The companies will work together to engineer immune cells with fully human chimeric antigen receptors (CARs) and T-cell receptors (TCRs) directed to disease-specific cell surface antigens. This precise and targeted engagement is designed to provide a superior potential to facilitate recognition and killing of tumor cells.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Under the terms of the collaboration, Twist will leverage its proprietary single chain fragment variable (scFv) and VHH (nanobody) technologies from its Library of Libraries to discover unique target-specific binders. These targeting technologies will enable Adicet Bio&#x2019;s engineering and discovery of unique CARs used in the generation of novel gamma delta CAR T cell products. Twist will receive an upfront technology license fee for each program as well as clinical and regulatory milestones and royalties for any product resulting from the selected targets.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">&#x201c;We are excited to leverage Twist&#x2019;s proprietary antibody discovery capabilities to potentially rapidly identify and optimize unique antibodies against key targets to further enhance our pipeline, both in cancer and other diseases,&#x201d; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Arial;">said Chen Schor</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Arial;">, President and Chief Executive Officer of Adicet. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">&#x201c;We&#x2019;ve selected five key targets where we believe our expertise in gamma delta T cell therapies could be augmented with</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Arial;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Twist&#x2019;s ability to identify highly potent, specific antibodies and look forward to a robust partnership.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">&#x201c;There is huge potential in using gamma delta T cells for the treatment of a wide range of cancers, and Adicet is leading the development in this field,&#x201d; commented Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. &#x201c;We look forward to partnering with Adicet to translate these target-engagement technologies into next-generation off-the-shelf, CAR-T therapies and to potentially accelerate the treatment of patients with cancer.&#x201d;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">About Adicet Bio</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of &#x201c;off-the-shelf&#x201d; gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">http://www.adicetbio.com</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">Forward-Looking Statements &#x2013; Adicet Bio</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">This press release contains &#34;forward-looking statements&#34; of Adicet within the meaning of the Private Securities Litigation Reform Act of 1995 relating to business and operations of Adicet including, but not limited to, express or implied statements regarding the potential benefits resulting from the collaboration with Twist to our business or strategy, including our ability to rapidly identify and optimize unique antibodies and related target-engagement technologies to facilitate our CAR pipeline, the payment of upfront license fees and potential milestone and royalty payments under the collaboration, the expected potential therapeutic effects of Adicet&#x2019;s product candidates, and expectations regarding the timing and success of preclinical and clinical development of Adicet&#x2019;s product candidates, including in connection with the collaboration. Any forward-looking statements in this press release are based on management&#x2019;s current expectations and beliefs of future events, and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements, including without limitation, the effect of COVID-19 on Adicet&#x2019;s business and financial results, including with respect to disruptions to its clinical trials and business operations; future clinical studies may fail to demonstrate adequate safety and efficacy of our product candidates, which would prevent, delay, or limit the scope of regulatory approval and commercialization; regulatory approval processes of the FDA and comparable foreign regulatory authorities are lengthy, time-consuming, and inherently unpredictable; as well as those risks and uncertainties set forth in Adicet&#x2019;s most recent annual report on Form 10-K and subsequent filings with the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Securities and Exchange Commission</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;"> (SEC). For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause Adicet&#x2019;s actual results to differ from those contained in the forward-looking statements, see the section entitled &#x201c;Risk Factors&#x201d; in Adicet&#x2019;s most recent annual report on Form 10-K and periodic reports on Form 10-Q and Form 8-K filed with the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">SEC</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">, as well as discussions of potential risks, uncertainties, and other important factors in Adicet&#x2019;s other filings with the </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">SEC</font><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">. All information in this press release is as of the date of the release, and Adicet undertakes no duty to update this information unless required by law.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">About Twist Bioscience Corporation</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by &#x201c;writing&#x201d; DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Follow us on </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Twitter</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;"> | </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Facebook</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;"> | </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">LinkedIn</font></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;"> | </font><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">YouTube</font></font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">Legal Notice Regarding Forward-Looking Statements</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">This press release contains forward-looking statements. All statements other than statements of historical facts contained herein, including but not limited to the ability of the collaboration to accelerate the discovery of gamma delta T cell therapies, are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Twist Bioscience&#x2019;s actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risks and uncertainties of the ability to attract new customers and retain and grow sales from existing customers; risks and uncertainties of rapidly changing technologies and extensive competition in synthetic biology could make the products Twist Bioscience is developing obsolete or non-competitive; the retention of employees of acquired companies and the ability of Twist Bioscience to successfully integrate acquired companies and to achieve expected benefits, risks of third party claims alleging infringement of patents and proprietary rights or seeking to invalidate Twist Bioscience&#x2019;s patents or proprietary rights; and the risk that Twist Bioscience&#x2019;s proprietary rights may be insufficient to protect its technologies. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Twist Bioscience&#x2019;s business in general, see Twist Bioscience&#x2019;s risk factors set forth in Twist Bioscience&#x2019;s Quarterly Report Form 10-Q filed with the Securities and Exchange Commission on August 9, 2021 and subsequent filings with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and Twist Bioscience specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">CONTACTS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">For Adicet Bio, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Anne Bowdidge</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">abowdidge@adicetbio.com</font></font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Janhavi Mohite</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Stern Investor Relations, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">212-362-1200</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">For Twist Bioscience</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">Angela Bitting<br>SVP, Corporate Affairs<br>925- 202-6211</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font><font style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Arial;">media@twistbioscience.com</font></font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img44277468_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img44277468_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #I UH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI*]R\7_!BQ-C+=^'BT$T:EOL[$E6 Z\GG->'R1O%(T<BE'0X93U!]*UA-3V
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M7FU%;>SAV%<[KQY\0(_&MAIZ&S-O<6[,7 .5.<=#^%<+1151BHJR$=E\*O\
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M_P"1JTC_ *^X_P#T*LG1A;8=SZ^'2BD7[H^E+7"4%%%% !7AWQ[_ ./W1O\
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M %U_QKPVMJ'P"9W'PD_Y*%9_]<G_ *5]*72>;:31_P!Y"/TKYK^$G_)0K/\
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M(=R0J/D0^_J15'XG_#;5=;UU-4T2W28R(%F3<$((X!Y]A6:K1<K#L<%\*O\
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MD_I7N%>8_%KP5JWBD:=/I,:RO;[@\98*3G'()K2BTIIL3/GNEKM/^%2^-/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!E>(-#M]?TN2SGX)Y1Q_"W:O*;KX<^
M((+@QP0)<1YXD5POZ$U[7142@I;G?A,QK85.,-5V9YQX?^&4<96XUF02-U$"
M=/H?6O0;>V@M(%AMXEBC48"J, 5-13C%1V,<1BZV(=ZC_P @HHHJCF"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img44277468_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img44277468_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *Y! \# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7$46>GF.%S^=/BFBG3?#(DB'^)&!'Z4KK85U>P^BBBF,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1110 R2*.9"DJ*Z'JK#(IL-M;VP(@@BB!ZB- O\ *I:*+"LKW"BBB@84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R
M6&*9=LL:2+Z,H(I8XTB0)&BHHZ!1@4ZBBP6"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ3
M_A>E[_T X/\ O^?\*]KKY7_X0OQ/_P!"_J7_ (#-_A0!WO\ PO2]_P"@'!_W
M_/\ A1_PO2]_Z <'_?\ /^%<%_PA?B?_ *%_4O\ P&;_  JK?^'=9TJW%QJ&
MEWEK"6"AYH64$GMD_0_E0!Z/_P +TO?^@'!_W_/^%'_"]+W_ * <'_?\_P"%
M>2UKVOA;7[ZVCN;71KZ>"0922.!F5A[$"@#T/_A>E[_T X/^_P"?\*OZ'\8[
MK5]>L-.?1X8UNITA+B8DKN.,XQS7F?\ PA?B?_H7]2_\!F_PK8\)^$_$-KXO
MT>XN-$OXH8[R)WD>W8*H##))Q0!](4444 %%%% !1110 4444 %%%% &1XFU
M6?1/#E[J=M;+<26R>9Y3-@$ C/(]!D_A7E?_  O2]_Z <'_?\_X5[)>6L=]8
MSVDPS%/&T3CV88/Z&OD>[M9;*]GM)EVRP2-&X/9E.#^HH ^D_ ?C'_A,M+N;
MJ2V2VF@F\MHE?=Q@$'.._(_"NLKPGX):E]G\1WVG,V%NK<.H]60\?HS?E7NU
M !5#6M231M$O=2D *VT+2[2<;B!P/Q.!^-7Z\Y^,NJ_8O!R6*-B2^G52/]A?
MF/ZA?SH YK_A>E[_ - .#_O^?\*]/\)Z^OB?PW:ZJL0B:7<'C#;MC!B",_AG
M\:^5J]I^!^J[[+4](=N8Y%N(P>I##:WX#:OYT >N4444 <]XR\2CPIX<EU/R
M1-('6..)FVAV)]?ID_A7FO\ PO2]_P"@'!_W_/\ A5SXY:EBWTK2U;EF>XD7
MZ#:O\VKQF@#ZB\%>(KGQ3X>75+FS6U$DK+&JN6#*O&<D>NX?A71UC^%]+_L;
MPOIFGE2KPVZAQ_MD9;_QXFMB@ HHHH **** "BBB@ HHHH **** /(=9^,MW
MI>N:AIZZ/#(MK<R0!S,06"L5SC'M6UX$^)%QXPUR;3Y=-BMECMFGWK*6)PRK
MC&/]JO%_%W_(YZ[_ -A&X_\ 1C5V/P1_Y'2\_P"P>_\ Z,CH ][HHHH ****
M "BBB@ HHHH **** "BBB@ KCO$GQ*\/^&Y7MY)GN[Q.&@MQN*GT9N@^G7VK
MFOBMX[FTO_B0:5,T=TZAKJ9#@QJ>B ]B1R3V&/7CQ#K0!ZQ>?'+4&<_8M&MH
MD_Z;2,Y_3;54?&_7<C.FZ<1WP'_^*KD='\$>)->A$VGZ5,\+#(E<B-"/8L0#
M^%:<GPJ\8HA;^RE;'9;B,G_T*@#M--^.4#,J:GHSQK_%);2AO_'2!_.O1="\
M3Z/XD@,NEWJ3%1EXSE73ZJ>?QZ5\Q:GHNJ:-((]2L+BU8_=\V,J&^AZ'\*9I
M=Q?VVIV\NER3)>[P(3#G>6/  QUSZ=Z /KFBLW0FU1]$M#K20KJ)C'G"+[N?
M\<8SCC.<<5I4 %%%% !1110 4444 %%%% !1110!XS=?&Z\M[N:$:) 1&[(#
MYYYP<>E1?\+TO?\ H!P?]_S_ (5Q5_X.\2OJ-TZ:#J+*TKD$6[8(R?:J_P#P
MA?B?_H7]2_\  9O\* .]_P"%Z7O_ $ X/^_Y_P */^%Z7O\ T X/^_Y_PKSN
M\\,:[IUJ]U>Z/?6]NF-\LL#*JY.!DD>I K)H ]:_X7I>_P#0#@_[_G_"C_A>
ME[_T X/^_P"?\*\[L_#&NZC:I=66CWUQ;OG9+% S*V#@X('J"*G_ .$+\3_]
M"_J7_@,W^% 'H5K\;KRXNX83HD $CJA/GGC)QZ5[-7R_8>#O$J:C;.^@ZBJK
M*A)-NV ,CVKZ@H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "O.?C5_R)$/_ %_1_P#H+UZ-7G/QJ_Y$
MB'_K^C_]!>@#P"OIWX=?\D^T;_KB?_0C7S%7T[\.O^2?:-_UQ/\ Z$: .HHH
MHH **** "BBB@ HHHH **** "BBB@ KYM^*>E_V9X]O2J[8[L+<I[[AAO_'@
MU?25>0?''2]UOI6K(O*LUM(WU&Y1^C_G0!YSX'U/^R/&NDW9;:@N!&Y/0*_R
M$_DV:^I:^.P2I!!P1T-?66@ZB-7T#3]1!!-S;I(V.S$<C\#D4 :5>!_&C5?M
M?BR#3U8E+& 9'H[_ #'_ ,=V5[TS!%+,0%'))[5\G>(-3.L^(=0U$YQ<3NZ@
M]ES\H_ 8'X4 9M=E\+M5.E^/+$%L17>;9_?=]W_QX+7.1Z5<2Z'<:LH_T>&=
M(&^K*Q_3:/\ OH55M[B2UN8KB%MLL3AT;T8'(/Z4 ?8%%5-.O8]3TRUOH?\
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M'XYH ^G**HZ3JMKK>E6^I64F^WG3<I/4>H/H0>#[U>H **** "BBB@ HHHH
M**** "BBB@ HHHH X[XJ?\DVU;_MC_Z.2OFNOI3XJ?\ )-M6_P"V/_HY*^:Z
M!'TI\*_^2;:3_P!MO_1SUV-<=\*_^2;:3_VV_P#1SUV- PHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "O.?C5_R)$/_ %_1_P#H+UZ-7G/QJ_Y$B'_K^C_]!>@#P"OIWX=?\D^T
M;_KB?_0C7S%7T[\.O^2?:-_UQ/\ Z$: .HHHHH **** "BBB@ HHHH ****
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M5(*6<20#'KC<?U8C\*X2IKJYFO+J6YN'+S2L7=CU)- &_P##_2_[6\<Z5;L
M42;SGR.,(-V/QP!^-?4%>)? _3/,U+4]5=>(8E@0D=V.3CZ!1^=>VT %%%%
M!1110 4444 %%%% !1110 4444 ?*?B[_D<]=_["-Q_Z,:NQ^"/_ ".EY_V#
MW_\ 1D=<=XN_Y'/7?^PC<?\ HQJ['X(_\CI>?]@]_P#T9'0(][HHHH&%%%%
M!1110 4444 %%%% !1110 4444 %4[O2M.O_ /C]L+6Y[?OH5?\ F*N44 >;
M>,/A1I6HV$USHENMEJ"*66.,XCE_V<=%/H1CWKP0@J2"""."#VK[$KY,\0M
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M<@TZJ*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMH5AA0)&OW5':I*W7F=:O;4Y/5-1U<^(SIUA<!-R@JK(N/NY/)'UI_D>+O\
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M+GN>-C(3]JVUN=-X*O96:>R9B8U7S$S_  \X(_45V%<]X7T67389)[D!9Y0
M$_NK_B:Z&NJBFH*YZ.%C*-)*04445J= 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'G/B>]DN]:F1F/EPGRT7TQU/XG^E8U
M=;XG\/W$EX]]:1F59,&1%&6!]0.]8%MH^H74PCCM)02>2RE0/J37G5(2YW<\
M.O3J>U=T=EX1NI+C1MDA)\F0HI/I@$?S_E6_5#2--72M/2V4[FSN=O5C5^NZ
MFFHI,]BC%QII2W"BBBK-#DO$1"^*=*)( #1DD_[]=++=6?E-YL\'EX^;<PQB
MJ6J:!:ZO.DMQ),K(NT",@#&<]P:HCP5IH(/G71]MZ_\ Q-8VG%NRW.7EJPG)
MQ5T_,J>$B#JNHFWR+0GY1_P([?TS7756L;"VTZ#R;6,(N<GN2?4FK-73BXQL
MS6C3=."BSG_&7_(#'_79?Y&M32?^0-8_]>\?_H(HU/38=5M1;SM(J;@V4(!R
M/J#4]O MM;16Z$E(D"*6ZX QS247SMB4&JKGTL2UQWA^XBTG6M0LKMA$TCC:
MSG ."<<^X-=C6=J6B66J8:XC(D' D0X;%$XMM-;H*L)-J4=T9_BC4[5-'EMU
MF1YI<!55LX&0<G\JOZ!;M:Z%:1."&VEB#VR2?ZU6L_"NF6<PEVR3,IR/-8$
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MM3J5[:A1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M69?:]IVGR&*>?]X.J("Q'UQTI.26K)E*,5>3L:=%4K'5K'4<_9;A78=5/##\
M#5VA-/5#4E)73"BBBF,**** "BBB@ HHHH **** "BBB@ HK+O/$.FV,IBEN
M-T@."J MCZU/8:K9:DI-K.'*]5(PP_ U*G%NUR%4@WRIZEVBBBJ+"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** .4\5:'/=2B^M4,C;=LB*.>.A'K_P#JKD4M+F23
MRTMY6?IM"'->LT5SSPZD[W.*K@HU)<U[&'X9T>32[-VGP)YB"R_W0.@_4UN4
M45M&*BK(ZH04(J*"BBBJ+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
B**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>acet-20210913_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-09-13T08:11:43.2562+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="acet-20210913.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>acet-20210913_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-09-13T08:11:43.2512+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOrganizationsAbstract" xlink:label="us-gaap_HealthCareOrganizationsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_HealthCareOrganizationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Health Care Organizations [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationsAbstract" xlink:to="us-gaap_HealthCareOrganizationsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>acet-20210913.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-09-13T08:11:43.1970+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.adicetbio.com/20210913" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:acet="http://www.adicetbio.com/20210913" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="acet-20210913_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="acet-20210913_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>acet-20210913_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="acet-20210913.xsd" xlink:type="simple"/>
    <context id="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001720580</identifier>
        </entity>
        <period>
            <startDate>2021-09-13</startDate>
            <endDate>2021-09-13</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_93798d6e-35e1-4928-a295-4eb22b36ffc7">0001720580</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_ce5e52bf-24ea-4f12-acd4-11ba23d2eb9b">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_ad3148f1-9990-4bb3-bb17-74857b48498f">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_8a241946-ae7b-441a-9c95-d0046f22409c">2021-09-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_aed735fb-6834-46bc-9dd7-e6d494bc66db">Adicet Bio, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_fb4ba229-ed0f-4eeb-8393-497fd8f442da">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_2159da06-2376-4876-ae89-d239e2b7c0ce">001-38359</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_cc045c55-8701-4a57-ae15-b12d2556c0b0">81-3305277</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_7413b0be-df56-431f-b578-2293db1f069e">200 Clarendon Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_d5ea3e72-61dd-4d00-8776-f5e482904fa2">Floor 6</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_37fe0a2d-cf70-4d06-bda1-dcee1b6e1213">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_4aa4db30-45ec-45bc-8106-544049c751cb">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_59abc986-b8af-4bc3-bbb4-6f553820af3c">02116</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_d4262438-215e-4588-8d84-b75e371c7b08">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_c3036e14-7b28-4c06-9da1-bb2d199cfd62">503-9095</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_bcdb014e-22d0-42a8-9e7c-6766001924ed">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_7be2fef5-c739-4d64-b637-91b803c388f9">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_dc3db100-396e-4a37-9aa0-97c0e7b61499">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_37149958-c2a4-4727-9061-1a32efc47505">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_8dbdacf8-445b-4c33-ba30-e0add30e9f64">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_f0774688-6ada-42ae-9810-952390adff17">ACET</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_5d1914da-8a4b-4f82-81f5-425393dbbd8d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_8614d6a0-de07-4731-8dde-1a27ba5f0bb6">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_43d81381-b8a3-4fef-b1b1-a82dac16f60d"
      id="F_411aa4c1-f9ff-4dfe-b609-f611f45bfe52">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139977410712120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 13,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Adicet Bio, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001720580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-3305277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Clarendon Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Floor 6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">503-9095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACET<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;%!+ 0(4 Q0    ( -5!+5/NL%S,[@   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -5!+5.97)PC$ 8  )PG
M   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ U4$M4]O#;.Y7!   <Q$  !@              ("!#0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -5!+5.?H!OPL0(  .(,
M   -              "  9H,  !X;"]S='EL97,N>&UL4$L! A0#%     @
MU4$M4Y>*NQS     $P(   L              ( !=@\  %]R96QS+RYR96QS
M4$L! A0#%     @ U4$M4QPX9>H_ 0  / (   \              ( !7Q
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -5!+5,D'INBK0   /@!   :
M              "  <L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( -5!+5-ED'F2&0$  ,\#   3              "  ; 2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="acet-20210913.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="acet-20210913.htm">acet-20210913.htm</File>
    <File>acet-20210913.xsd</File>
    <File>acet-20210913_lab.xml</File>
    <File>acet-20210913_pre.xml</File>
    <File>acet-20210913ex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "acet-20210913.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "acet-20210913.htm"
     ]
    },
    "labelLink": {
     "local": [
      "acet-20210913_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "acet-20210913_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "acet-20210913.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "acet",
   "nsuri": "http://www.adicetbio.com/20210913",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "acet-20210913.htm",
      "contextRef": "C_43d81381-b8a3-4fef-b1b1-a82dac16f60d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "acet-20210913.htm",
      "contextRef": "C_43d81381-b8a3-4fef-b1b1-a82dac16f60d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.adicetbio.com/20210913/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000950170-21-001776-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-21-001776-xbrl.zip
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MOO5> T;I&YKM:/O=!="60^H+6]B&%U##$@PZU0W*?&Y17?>887)#>*Y7A_0
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M83P>RQ0W41#T.4BAQEN";BQ!3\[.R=%X$L93D;2:[;'H6_1IR&G<62H*E6L
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MZ(]<)H5B#MEUF[9M6BCVY+2M6Z1MR?',\)W/W9-"4ZD5E#:9^Y3 <9OOW(?
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MW>_BB9OO?]KOCK)Q^/[_ 5!+ P04    " #502U3@$:&EA@#  "^"0  $0
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MPS"I 4M19Y36.!5"OBX(?T1.@20 D9@Q:>)=4E>,TTC:EK)"1/XVI(W$&XS
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MI$6Y7'P:W. ![7] ^_<(\_C-;KHSSK_KLNX]9^6=KQGTV<C(?]MA9FR@@35
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4!08     !0 % $D!   ?.@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
